QQ客服 官方微博 反馈留言

	TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluorescent staining
	Shi D.; Liu W.; Zhao S.; Zhang C.; Liang T.; Hou G.
刊名	Journal of Cellular and Molecular Medicine
	2019
卷号	23期号:12页码:8305-8313
关键词	fluorescence imaging Phosphorautoradiography Radioiodine 125 TLR5 triple-negative breast cancer
DOI	10.1111/jcmm.14707
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4558615
专题	山东大学
作者单位	Key Laboratory for Experimental Teratology of the Ministry of Education and Biomedical Isotope Research Center, School of Medicine, Shandong
推荐引用方式 GB/T 7714	Shi D.,Liu W.,Zhao S.,et al. TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluorescent staining[J]. Journal of Cellular and Molecular Medicine,2019,23(12):8305-8313.
APA	Shi D.,Liu W.,Zhao S.,Zhang C.,Liang T.,&Hou G..(2019).TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluorescent staining.Journal of Cellular and Molecular Medicine,23(12),8305-8313.
MLA	Shi D.,et al."TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluorescent staining".Journal of Cellular and Molecular Medicine 23.12(2019):8305-8313.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。